What people report
Tesamorelin reviews: what people report
Read 28 people, 2 sitesPublished by PepVault
Of the 28 people whose Tesamorelin write-ups we read, 15 describe a change they wanted (9 a change in weight or appetite; 4 better sleep or vivid dreams; 4 more energy or strength), 1 noticed nothing and 16 describe something unwanted.
What people report
15 of the 28 people describe at least one change they wanted. Each bar counts the people who named anything in that group, once each, out of all 28; the line under it says what they named, and how many named it. 16 of them took Tesamorelin alongside other peptides at the same time.
What went wrong or did nothing
16 of the 28 people describe something they didn’t want, and 1 noticed nothing at all.
Your report
Taken Tesamorelin? What did you notice?
One tap to start. About 30 seconds, no account.

When people say it begins
0 of the 28 people say when they first noticed something; 28 don’t.
What people took it for
4 of the 28 people say what they took it for; 24 don’t.
How it’s thought to work
Shown in people
Tesamorelin is a lab-made copy of GHRH, the brain’s signal to release growth hormone, built to last longer in the blood. It makes the pituitary release more growth hormone, which raises IGF-1. In controlled trials in people with HIV it shrank the fat around the organs, and it is approved in the US as Egrifta for that use only.
Sources: Falutz et al., 2010: two trials in people with HIV, pooled; Stanley et al., 2014: liver fat in people with HIV
What studies show
Our research section has 12 study pages on Tesamorelin: 12 in people.
Two large trials in 806 people with HIV compared a daily tesamorelin shot with a dummy shot for 26 weeks; the fat around their organs fell by 15.4% more than on the dummy shot, and IGF-1 rose.
- Tesamorelin: visceral fat down 27.71 cm² in HIV lipodystrophy
- Tesamorelin shifted liver gene activity in HIV-related fatty liver
- Tesamorelin: denser, larger trunk muscles at 26 weeks in HIV
- Tesamorelin: no change in glucose control in type 2 diabetes
- Tesamorelin cut visceral and liver fat over 6 months in HIV patients
- Tesamorelin had little effect on simvastatin and ritonavir levels
- Tesamorelin cut visceral fat 15.4% vs placebo in HIV at 26 weeks
- Tesamorelin: 10.9% less visceral fat at 6 months in HIV patients
- Tesamorelin: visceral fat down 18% over 52 weeks in HIV patients
- Tesamorelin: 15.2% drop in visceral fat at 26 weeks in HIV
- Tesamorelin drug levels unaffected by age, size, race or HIV status
- Tesamorelin: model accurately predicted GH and IGF-1 over 14 days
- Tesamorelin in the library: how it works, half-life and evidence
- Is Tesamorelin legal? FDA, DEA and WADA status
- Tesamorelin dose guide
Where the reports run ahead of the studies
People here report less belly fat, as the trials found, and joint aches, numb hands and water retention, which the trials and the drug’s label list too. Where the reports run ahead: deeper sleep and more strength in people without HIV, which no trial has tested (PubMed, searched November 19, 2026).
Where the reports come from
28 people on 11 pages across 2 sites, written from August 2024 to October 2026. Read on November 19, 2026.
The largest single site, the Peptide Critic forum, gave 24 of the 28.
Peptide Critic, which runs its forum, also runs a shop on its own site that sells injection pens and supplies, not peptides.
Most people here took tesamorelin bought for research, often in the same shot as ipamorelin, at doses up to the label’s; the trials tested it in people with HIV.
- Peptide Critic forum, the tesamorelin protocol thread: 10 people
- rapamycin.news forum, the peptides and bioregulators thread: 4 people
- Peptide Critic forum, a thread on tesamorelin against CJC-1295: 3 people
- Peptide Critic forum, a thread on tesamorelin side effects and protocols: 3 people
- Peptide Critic forum, a thread on cycling tesamorelin: 2 people
- Peptide Critic forum, a thread on favourite stacks: 1 person
- Peptide Critic forum, a thread on tesamorelin alone or with ipamorelin: 1 person
- Peptide Critic forum, a thread on growth hormone against CJC-1295, ipamorelin and tesamorelin: 1 person
- Peptide Critic forum, a thread on peptides that surprised people: 1 person
- Peptide Critic forum, a thread on tesamorelin side effects: 1 person
- Peptide Critic forum, a thread on retatrutide and the kidneys: 1 person
Read and not counted
- A Peptide Critic forum staff member’s posts: The same account posts the forum’s vendor sales roundups, and the site runs its own store: the seller’s side of the counter, so not counted.
- A rapamycin.news member who supplies peptides to clients: Writes of the clients and family on the same nightly shot: the seller’s side of the counter, so not counted.
- A vendor review reposted on the Peptide Critic forum: A review of a shop, written about the seller; an advertisement, so not counted.
- Posts from people who take it through a doctor’s clinic and pass on the clinic’s advice: Advice, not what the person noticed.
- Posts where the change could not be put on Tesamorelin: Where a person named another peptide in the stack as the cause, the effect is counted on that one only.
- Reports about someone else (a wife, friends, family): Second-hand; only a person’s own report counts.
- Posts about dosing, timing, fasting and vendors with no effect named: Most posts in these threads; nothing noticed was said.
- Reddit and X: Not part of this count.
How we counted
We read every open write-up we could find by people who took Tesamorelin, on its own page, and counted each person once however often they posted, including those who noticed nothing. Sellers, clinics, shop reviews and anyone who earns on a sale are not counted, and neither is a search result’s snippet; the list above names what we read and left out. Write-ups lean positive, because people who notice nothing rarely write about it and expecting an effect can produce one.
Spot an error? feedback@pepvault.app. How we research. This page reports what people say; it is not medical advice.